Cutaneous T cell lymphoma

R Dummer, MH Vermeer, JJ Scarisbrick… - Nature Reviews …, 2021 - nature.com
Primary cutaneous T cell lymphomas (CTCLs) are a heterogeneous group of lymphomas
that present in the skin with no evidence of extracutaneous disease at the time of diagnosis …

A comprehensive update of the atypical, rare and mimicking presentations of mycosis fungoides

E Lebas, P Collins, J Somja, AF Nikkels - Dermatology and Therapy, 2021 - Springer
Introduction Mycosis fungoides (MF) is the most frequent subtype of primary cutaneous T cell
lymphomas (pCTCL). The diagnosis may be particularly difficult in the early stages as well …

Development of cutaneous T-cell lymphoma following biologic treatment: A systematic review

L Schaefer, N Comfere, O Sokumbi - American Journal of Clinical …, 2023 - Springer
Background Cutaneous T-cell lymphoma following biologic therapy is extremely rare.
Objective The aim of this systematic review was to investigate the development of cutaneous …

Determination of T-cell clonality and expression profiles of Toll-like receptors signaling pathway genes and related miRNAs in patients with mycosis fungoides

M Seçme, Y Dodurga, NÇ Demirkan, N Kaçar… - Gene, 2024 - Elsevier
Cutaneous T-cell lymphomas (CTCL) encompass a group of diseases characterized by the
presence of malignant clonal CD4+ T lymphocytes in the skin. Mycosis fungoides (MF) is the …

A practical guide to the diagnosis, evaluation, and treatment of cutaneous T-cell lymphoma

S Shimshak, O Sokumbi, N Isaq, A Goyal… - Dermatologic …, 2023 - derm.theclinics.com
Cutaneous T-cell lymphomas (CTCLs) encompass a group of clinically heterogenous non-
Hodgkin lymphomas characterized by the infiltration of the skin by neoplastic T-lymphocytes …

Clinical outcomes of advanced-stage cutaneous lymphoma under low-dose gemcitabine treatment: real-life data from the German cutaneous lymphoma network

C Blazejak, R Stranzenbach, J Gosman, T Gambichler… - Dermatology, 2022 - karger.com
Background: Gemcitabine is an effective single-agent chemotherapy used in advanced
stages of cutaneous T-cell lymphoma (CTCL). However, gemcitabine used in the current …

Cancer alters the metabolic fingerprint of extracellular vesicles

M Palviainen, K Laukkanen, Z Tavukcuoglu… - Cancers, 2020 - mdpi.com
Simple Summary Cancer changes cell metabolism. In this study, we explored if the
metabolic rewiring also alters the metabolite content of cancer-derived extracellular vesicles …

Cutaneous T-cell lymphoma: Diagnosing subtypes and the challenges

C Hague, N Farquharson, L Menasce… - British Journal of …, 2022 - magonlinelibrary.com
Cutaneous T-cell lymphoma is a rare type of extranodal non-Hodgkin's lymphoma that
primarily affects the skin. The uncertain pathogenesis and variable clinical presentation …

[HTML][HTML] Psoriasiform mycosis fungoides–cutaneous T-cell lymphoma in an African American

AC Miller, A Mattia, A Thompson, LA Temiz, S Adjei… - JAAD Case Reports, 2023 - Elsevier
Cutaneous T-cell lymphomas (CTCLs) are a group of neoplasms characterized by
monoclonal proliferation of skin-homing T cells that show considerable variation in clinical …

From Molecules to Microbes: Tracing Cutaneous T-Cell Lymphoma Pathogenesis through Malignant Inflammation

ER Gordon, LM Fahmy, MH Trager, O Adeuyan… - Journal of Investigative …, 2024 - Elsevier
The etiology of CTCL is a subject of extensive investigation. Researchers have explored
links between CTCL and environmental chemical exposures, such as aromatic …